Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

NCPDP Brings National Awareness to its Specialty Pharmacy Work Group at Asembia's 15th Annual Specialty Pharmacy Summit and NCPDP's May Work Group Meetings

Work Group Focuses on Standardization Efforts to Speed Time to Drug Therapy


News provided by

National Council For Prescription Drug Programs, Inc.

Apr 25, 2019, 07:05 ET

Share this article

Share toX

Share this article

Share toX

NCPDP
NCPDP

NEW YORK, April 25, 2019 /PRNewswire-PRWeb/ -- Committed to securing timely access to specialty medications for patients with chronic or complex conditions, NCPDP brings national awareness to its Specialty Pharmacy Work Group initiatives. The efforts include speaker presentations to Asembia's 15th Annual Specialty Pharmacy Summit, the nation's largest gathering in specialty pharmacy, and NCPDP's Work Group Meetings convening in May.

Cancer, hepatitis, multiple sclerosis and other chronic diseases often require a specialty medication. The current lack of standardization to process a specialty medication means it could take days, weeks and even months for a patient to get access to a prescribed treatment regimen—potentially threatening patient outcomes. NCPDP and its members are dedicated to enabling safe and timely access to these therapies.

We often take for granted the swift time to fill prescriptions, but that’s not the case with specialty medications. We want to make the prescriber’s job and patient journey easier by standardizing the many manual processes to speed time and access to specialty drug therapies.

Post this

"Imagine a loved one diagnosed with a complex or chronic disease that requires a specialty medication," said Lee Ann Stember, President & CEO of NCPDP. "We often take for granted the swift time to fill prescriptions, but that's not the case with specialty medications. We want to make the prescriber's job and patient journey easier by standardizing the many manual processes to speed time and access to specialty drug therapies."

The three sessions at Asembia aim to increase awareness of NCPDP's Specialty Pharmacy Work Group (WG18) and encourage attendees to participate in NCPDP's critically important work. Asembia's 15th Annual Specialty Pharmacy Summit is held April 29 to May 2 in Las Vegas and draws thousands of senior executives, key decision makers and other stakeholders in specialty pharmacy.

Three sessions at Asembia's Specialty Pharmacy Summit focus on NCPDP's Work in Specialty Pharmacy

  • John Hill, NCPDP's Executive Vice President & GM, and Pooja Babbrah, MBA, WG18 Co-Chair and PBM Practice Lead at Point-of-Care Partners, will co-present "How NCPDP is Improving Speed to Specialty Therapy." The session introduces attendees to NCPDP and reviews the specialty pharmacy work group's initiatives underway to automate manual processes and transactions to support specialty management.
  • For the second session, Julie Hessick, R.Ph., WG18 Co-Chair and Senior Director of Business Development at OneOme, and Jill Helm, Vice-President, Solution Management at Veradigm, will co-present "Real-Time Benefit Check: The Next Revolution in Healthcare." The session examines how RTBC helps reduce medication abandonment, improve medication adherence and outcomes, and enhance patient and provider satisfaction.
  • Presenting the third session, "Best Practices for Automating REMS in Workflow," are Babbrah, Shivani Patel, Senior Vice President Clinical Operations & Technology at Asembia, and Mark Sasala, subject matter expert in Specialty Pharmacy Technology at Creehan & Company, an Inovalon Company. The session will examine NCPDP's implementation guide and best practices for REMS transactions for the Telecommunication Standard for pharmacies to meet to dispense medications.

NCPDP's Work Group Meeting, May 5-6
NCPDP's Specialty Pharmacy Work Group will meet May 6 at the Westin Kierland Resort & Spa in Scottsdale, Arizona.

"Our dedicated pharmacists and stakeholders involved in specialty pharmacy are driven by industry need and personal passion to enable safe and timely access to these therapies," said Stember. "However, for us to develop comprehensive transactions for specialty pharmacy, we need more people, colleagues and business partners willing to share perspectives, knowledge and expertise."

Work Group 18 Specialty Pharmacy Co-Chairs are Babbrah, Hessick and Laura Topor, President, Granada Health, Inc. The work group meets quarterly and oversees the work of four task groups that meet via teleconference calls to work collaboratively with colleagues and competitors alike to develop solutions using NCPDP's consensus-building process.

NCPDP's specialty pharmacy work group will provide an update on the efforts of its four task groups:

  • WG18 Specialty Pharmacy Data Exchange Task Group will standardize documentation, reporting or data exchange to support programs and agreements between specialty pharmacy stakeholders such as specialty pharmacies, manufacturers, PBMs, hubs, data aggregators, and payers. This could occur via the creation of new standards or the modification of existing NCPDP standards.
  • WG18 Specialty Requirements for ePrescribing Task Group identifies opportunities to support the exchange of information needed before a prescription can be dispensed. This information is provided by the prescriber (or someone in the prescriber's office) and includes additional patient demographic and clinical information, order-specific clinical information and instructions related to delivery of the medication (i.e. to the patient or the clinic, nursing services required). This data would be added to the appropriate SCRIPT Standard and/or Specialized Standard transactions, depending on analysis.
  • WG18 Stakeholder Outreach and Education Task Group identifies and provides outreach to specialty pharmacy stakeholders to facilitate engagement in WG18. Educational opportunities will be identified and facilitated based on input from stakeholders.
  • WG18 Benefit Coverage Identification Task Group addresses the areas of opportunity related to determining if coverage is through the medical or pharmacy benefit.

The Specialty Pharmacy Work Group will also call for volunteers to pilot NCPDP's Specialty Pharmacy Data Reporting Standard, which supports specialty pharmacy operations and validates contractual obligations via a uniform data format, enabling pharmacies' submissions to multiple manufacturers.
Interested NCPDP members and non-members can click here for information on the May meeting and future events. Task group conference calls are open to NCPDP members and non-members. To participate in a task group, click here.

About NCPDP

Founded in 1977, NCPDP is a not-for-profit, ANSI-accredited, Standards Development Organization with more than 1,600 members representing virtually every sector of the pharmacy services industry. Our diverse membership provides leadership and healthcare business solutions through education and standards, created using the consensus building process. NCPDP has been named in federal legislation, including HIPAA, MMA, and HITECH. NCPDP members have created standards such as the Telecommunication Standard and Batch Standard, the SCRIPT Standard for ePrescribing, the Manufacturers Rebate Standard and more to improve communication within the pharmacy industry. Our data products include dataQ®, a robust database of information on more than 80,000 pharmacies, resQ™, an industry pharmacy credentialing resource, and HCIdea®, an innovative prescriber database that provides continually updated information on more than 2.5 million prescribers. NCPDP's RxReconn® is a legislative tracking product for real-time monitoring of pharmacy-related state and national legislative and regulatory activity. For more information about NCPDP Standards, Data Services, Products, Educational Programs and Work Group meetings, go online at http://www.ncpdp.org or call 480.477.1000.

SOURCE National Council For Prescription Drug Programs, Inc.

Related Links

http://www.ncpdp.org

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.